KBC Group NV Sells 11,373 Shares of Axon Enterprise, Inc $AXON

KBC Group NV lowered its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 42.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,572 shares of the biotechnology company’s stock after selling 11,373 shares during the period. KBC Group NV’s holdings in Axon Enterprise were worth $8,730,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the stock. GWN Securities Inc. increased its holdings in shares of Axon Enterprise by 47.0% in the second quarter. GWN Securities Inc. now owns 1,386 shares of the biotechnology company’s stock worth $777,000 after purchasing an additional 443 shares during the period. North Dakota State Investment Board lifted its stake in Axon Enterprise by 4.3% during the second quarter. North Dakota State Investment Board now owns 2,248 shares of the biotechnology company’s stock worth $1,260,000 after purchasing an additional 92 shares during the last quarter. 71 West Capital Partners increased its position in shares of Axon Enterprise by 9.2% during the 2nd quarter. 71 West Capital Partners now owns 1,394 shares of the biotechnology company’s stock valued at $781,000 after purchasing an additional 117 shares during the last quarter. Checchi Capital Advisers LLC bought a new stake in Axon Enterprise in the 2nd quarter worth approximately $222,000. Finally, McAdam LLC purchased a new position in shares of Axon Enterprise during the second quarter worth approximately $214,000. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on AXON. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. Needham & Company LLC reissued a “buy” rating on shares of Axon Enterprise in a report on Thursday, August 6th. JPMorgan Chase & Co. upped their price target on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Barclays upped their target price on Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, Morgan Stanley boosted their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $730.92.

Axon Enterprise Price Performance

AXON opened at $612.83 on Friday. The stock has a 50-day moving average price of $526.06 and a 200-day moving average price of $474.40. The firm has a market cap of $49.79 billion, a PE ratio of 254.29, a P/E/G ratio of 12.50 and a beta of 1.39. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $794.29. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm had revenue of $904.39 million for the quarter, compared to the consensus estimate of $876.42 million. During the same period in the prior year, the company posted $2.12 earnings per share. The company’s quarterly revenue was up 35.3% on a year-over-year basis. Sell-side analysts predict that Axon Enterprise, Inc will post 2.04 earnings per share for the current fiscal year.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Northland Securities raised several future earnings estimates. The firm lifted its FY2027 EPS forecast to $6.49 from $5.53 and increased estimates for Q1–Q4 2027, as well as Q3 2026. The revisions suggest stronger anticipated earnings from Axon’s connected-device, software, AI and public-safety technology businesses.
• Positive Sentiment: Axon raised its 2026 revenue-growth outlook to 32%–34%. Management cited strong momentum in connected devices, international demand, counter-drone products and AI-enabled software, supported by approximately $15.1 billion in future contracted bookings. Axon Enterprise Is Up 17.8% After Raising 2026 Revenue Outlook
• Neutral Sentiment: Recent quarterly results exceeded expectations. Second-quarter revenue increased 35.3% year over year to $904.4 million and topped consensus, while adjusted EPS also beat estimates. However, reported net income and diluted EPS declined, highlighting the trade-off between rapid expansion and near-term profitability. The 5 Most Interesting Analyst Questions From Axon’s Q2 Earnings Call
• Negative Sentiment: Northland reduced its FY2026 EPS forecast to $3.12 from $3.26 and cut its Q4 2026 estimate to $1.29 from $1.55. These downgrades indicate some near-term earnings pressure even though longer-term forecasts improved.
• Negative Sentiment: Insider selling added pressure. A report attributed a 6.5% decline to recent insider sales, which can raise concerns about valuation or management’s view of near-term upside. Axon Enterprise Trading Down Following Insider Selling
• Negative Sentiment: Valuation and margins remain risks. With a very high earnings multiple and reported margin contraction, investors may be demanding clearer evidence that revenue growth will translate into sustained profit growth.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 13,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the sale, the president owned 169,125 shares of the company’s stock, valued at $82,609,106.25. This trade represents a 7.14% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of Axon Enterprise stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the sale, the insider owned 34,024 shares of the company’s stock, valued at $16,501,640. This represents a 4.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 68,989 shares of company stock worth $36,016,932. 4.20% of the stock is owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.